NCX 4016

NCX 4016

Stock Code: 3575244
Manufacturer Part No: SML1669-5MG
Order Now for 7 day delivery
£124.94 (exc VAT) per 5MG
Quantity: - +

Biochem/physiol Actions


NCX-4016 can prevent the progression of cisplatin-resistant human ovarian cancer xenografts in mice. It can also regulate the expression of B-cell lymphoma 2 (Bcl-2) proteins in ovarian cancer cells. Hence, NCX-4016 is considered a promising therapeutic option against carcinoma.


NCX 4016 (nitroaspirin) is nitroderivative of aspirin that combines cyclooxygenase inhibitor with an NO donor. NCX 4016 improves postischemic ventricular dysfunction and to reduce myocardial infarct size in rabbit.


Packaging


5, 25 mg in glass bottle

Colourwhite to beige
Quality Level100
InChI keyIOJUJUOXKXMJNF-UHFFFAOYSA-N
InChI1S/C16H13NO7/c1-11(18)23-15-8-3-2-7-14(15)16(19)24-13-6-4-5-12(9-13)10-22-17(20)21/h2-9H,10H2,1H3
ManufacturerSIGMA-ALDRICH
SolubilityDMSO: 25 mg/mL, clear
Formpowder
Assay≥98% (HPLC)

There are no downloads for this product.